MIR3147 host gene (MIR3147HG)

MIR3147 host gene (MIR3147HG) is listed as a long non-coding RNA gene in genomic annotation databases. It has no well-established molecular function, disease associations, or role as a therapeutic target in current scientific literature. There is no experimental evidence for its biological activity, interaction with drugs, or use in biomarker or safety monitoring[4]. By convention, a "host gene" in this context is a gene that contains within its sequence a microRNA (miRNA)—here, miR-147. The properties and roles attributed to miR-147 (such as inflammation, cancer cell proliferation, response to infection) are not automatically assigned to the host gene itself; these functions are mediated by the miRNA product, not the host transcript[1][2][5]. The host gene may require future research for characterization, and may have regulatory functions, but as of now, its therapeutic relevance and molecular details remain undefined. MIR3147HG should not be confused with MIR31HG (MIR31 host gene), which is a distinct lncRNA with described roles in cancer and cellular regulation[3]. Search results support that MIR3147HG is a valid genomic entry, but lack experimental or clinical data describing its function, molecular role, or therapeutic relevance[4]. There is insufficient scientific data to annotate MIR3147HG as a therapeutic target or for any of the requested biological and pharmacological categories. Its designation is correct as a gene, but it is currently an uncharacterized entity in biomedical research.

Other names

MIR3147 host geneMIR3147HG